help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Endocrinology, doi:10.1210/en.2008-1499
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Google Scholar
Right arrow Articles by Waclawik, A.
Right arrow Articles by Ziecik, A. J.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Waclawik, A.
Right arrow Articles by Ziecik, A. J.
Endocrinology Vol. 150, No. 8 3823-3832
Copyright © 2009 by The Endocrine Society

Estradiol-17β, Prostaglandin E2 (PGE2), and the PGE2 Receptor Are Involved in PGE2 Positive Feedback Loop in the Porcine Endometrium

Agnieszka Waclawik, Henry N. Jabbour, Agnieszka Blitek and Adam J. Ziecik

Institute of Animal Reproduction and Food Research of Polish Academy of Sciences (A.W., A.B., A.J.Z.), Tuwima 10, 10-747 Olsztyn, Poland; and Medical Research Council Human Reproductive Science Unit (H.N.J.), The Queens Medical Research Institute, Edinburgh EH16 4TJ, United Kingdom

Address all correspondence and requests for reprints to: Agnieszka Waclawik, Institute of Animal Reproduction and Food Research of Polish Academy of Sciences, Tuwima 10, 10-747 Olsztyn, Poland. E-mail: waclawik{at}pan.olsztyn.pl.

Before implantation, the porcine endometrium and trophoblast synthesize elevated amounts of luteoprotective prostaglandin estradiol-17β (E2) (PGE2). We hypothesized that embryo signal, E2, and PGE2 modulate expression of key enzymes in PG synthesis: PG-endoperoxide synthase-2 (PTGS2), microsomal PGE synthase (mPGES-1), PGF synthase (PGFS), and PG 9-ketoreductase (CBR1) as well as PGE2 receptor (PTGER2 and -4) expression and signaling within the endometrium. We determined the site of action of PGE2 in endometrium during the estrous cycle and pregnancy. Endometrial tissue explants obtained from gilts (n = 6) on d 11–12 of the estrous cycle were treated with vehicle (control), PGE2 (100 nM), E2 (1–100 nM), or phorbol 12-myristate 13-acetate (100 nM, positive control). E2 increased PGE2 secretion through elevating expression of mPGES-1 mRNA and PTGS2 and mPGES-1 protein in endometrial explants. By contrast, E2 decreased PGFS and CBR1 protein expression. E2 also stimulated PTGER2 but not PTGER4 protein content. PGE2 enhanced mPGES-1 and PTGER2 mRNA as well as PTGS2, mPGES-1, and PTGER2 protein expression. PGE2 had no effect on PGFS, CBR1, and PTGER4 expression and PGF2{alpha} release. Treatment of endometrial tissue with PGE2 increased cAMP production. Cotreatment with PTGER2 antagonist (AH6809) but not PTGER4 antagonist (GW 627368X) inhibited significantly PGE2-mediated cAMP production. PTGER2 protein was localized in luminal and glandular epithelium and blood vessels of endometrium and was significantly up-regulated on d 11–12 of pregnancy. Our results suggest that E2 prevents luteolysis through enzymatic modification of PG synthesis and that E2, PGE2, and endometrial PTGER2 are involved in a PGE2 positive feedback loop in porcine endometrium.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2009 by The Endocrine Society